Logo image of ALHEX.PA

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

EPA:ALHEX - Euronext Paris - Matif - FR0004159473 - Common Stock - Currency: EUR

28.9  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALHEX. ALHEX was compared to 35 industry peers in the Household Durables industry. The financial health of ALHEX is average, but there are quite some concerns on its profitability. ALHEX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALHEX was profitable.
In the past year ALHEX had a positive cash flow from operations.
ALHEX had positive earnings in 4 of the past 5 years.
In the past 5 years ALHEX always reported a positive cash flow from operatings.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.48%, ALHEX is in line with its industry, outperforming 45.71% of the companies in the same industry.
ALHEX has a Return On Equity of 6.20%. This is comparable to the rest of the industry: ALHEX outperforms 45.71% of its industry peers.
ALHEX has a Return On Invested Capital of 6.12%. This is in the lower half of the industry: ALHEX underperforms 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALHEX is significantly below the industry average of 16.45%.
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROIC 6.12%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ALHEX has a Profit Margin of 1.94%. This is in the lower half of the industry: ALHEX underperforms 60.00% of its industry peers.
ALHEX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.79%, ALHEX is doing worse than 68.57% of the companies in the same industry.
In the last couple of years the Operating Margin of ALHEX has declined.
ALHEX has a Gross Margin of 19.40%. This is amonst the worse of the industry: ALHEX underperforms 85.71% of its industry peers.
In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.
Industry RankSector Rank
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALHEX is still creating some value.
ALHEX has about the same amout of shares outstanding than it did 1 year ago.
ALHEX has a better debt/assets ratio than last year.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.48 indicates that ALHEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALHEX has a Altman-Z score of 2.48. This is in the better half of the industry: ALHEX outperforms 62.86% of its industry peers.
The Debt to FCF ratio of ALHEX is 9.35, which is on the high side as it means it would take ALHEX, 9.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.35, ALHEX is in line with its industry, outperforming 57.14% of the companies in the same industry.
ALHEX has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.24, ALHEX is doing good in the industry, outperforming 62.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Altman-Z 2.48
ROIC/WACC0.91
WACC6.76%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

ALHEX has a Current Ratio of 1.30. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.30, ALHEX is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
ALHEX has a Quick Ratio of 1.01. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
ALHEX has a better Quick ratio (1.01) than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.01
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for ALHEX have decreased strongly by -56.88% in the last year.
Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.88%.
Measured over the past years, ALHEX shows a decrease in Revenue. The Revenue has been decreasing by -9.93% on average per year.
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%

3.2 Future

The Earnings Per Share is expected to grow by 35.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y21.22%
EPS Next 2Y35.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.96, which indicates a correct valuation of ALHEX.
ALHEX's Price/Earnings ratio is in line with the industry average.
ALHEX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.29 indicates a reasonable valuation of ALHEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 36.28. ALHEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.96
Fwd PE 11.29
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHEX indicates a rather cheap valuation: ALHEX is cheaper than 94.29% of the companies listed in the same industry.
ALHEX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.04
EV/EBITDA 3.01
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

ALHEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALHEX's earnings are expected to grow with 35.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y35.07%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

ALHEX has a Yearly Dividend Yield of 1.66%. Purely for dividend investing, there may be better candidates out there.
ALHEX's Dividend Yield is comparable with the industry average which is at 4.80.
Compared to the average S&P500 Dividend Yield of 2.40, ALHEX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.66%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y35.07%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

HEXAOM

EPA:ALHEX (8/5/2025, 7:00:00 PM)

28.9

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-11 2025-08-11
Inst Owners13.9%
Inst Owner ChangeN/A
Ins Owners2.81%
Ins Owner ChangeN/A
Market Cap200.57M
Analysts86
Price Target37.49 (29.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.66%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.96
Fwd PE 11.29
P/S 0.28
P/FCF 23.04
P/OCF 13.17
P/B 0.88
P/tB 1.48
EV/EBITDA 3.01
EPS(TTM)2.07
EY7.16%
EPS(NY)2.56
Fwd EY8.86%
FCF(TTM)1.25
FCFY4.34%
OCF(TTM)2.19
OCFY7.59%
SpS104.97
BVpS32.84
TBVpS19.59
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROCE 7.89%
ROIC 6.12%
ROICexc 12.79%
ROICexgc 39.35%
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
FCFM 1.2%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexcg growth 3Y-17.24%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Debt/EBITDA 1.55
Cap/Depr 43.08%
Cap/Sales 0.9%
Interest Coverage 250
Cash Conversion 42.9%
Profit Quality 61.63%
Current Ratio 1.3
Quick Ratio 1.01
Altman-Z 2.48
F-Score6
WACC6.76%
ROIC/WACC0.91
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
EPS Next Y21.22%
EPS Next 2Y35.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-41.69%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.7%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-65.3%
OCF growth 3Y-21.91%
OCF growth 5YN/A